MeSH Browser

MeSH Heading: Ibandronic Acid
Tree Number(s): D02.705.429.500.844
Unique ID: D000077557
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000077557
Scope Note: Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.
Entry Term(s): (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate; 1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate; BM 21.0955; BM 210955; BM-21.0955; BM-210955; Bondronat; Boniva; Bonviva; Ibandronate; Ibandronate Sodium; Ibandronate Sodium Anhydrous; Ibandronic Acid, Sodium Salt, Monohydrate; RPR 102289A; RPR-102289A
Pharm Action: Bone Density Conservation Agents
Registry Number: UMD7G2653W
Related Numbers: 114084-78-5; 23Y0B94E49; J12U072QL0
CAS Type 1 Name: Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-
Public MeSH Note: 2019; IBANDRONIC ACID was indexed under DIPHOSPHONATES 1992-2018
History Note: 2019 (1992)
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/07/03

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Ibandronic Acid MeSH Descriptor Data 2024